share_log

Barrington Research Maintains Outperform on Concentrix, Lowers Price Target to $98

Benzinga ·  Jun 29, 2023 12:19

Barrington Research analyst Vincent Colicchio maintains Concentrix (NASDAQ:CNXC) with a Outperform and lowers the price target from $165 to $98.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment